Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$92.37 USD

92.37
11,670,925

-0.97 (-1.04%)

Updated Jun 28, 2024 04:00 PM ET

After-Market: $92.38 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (163 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up

Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.

Edwards Lifesciences (EW) Matches Q2 Earnings Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0% and 1.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Edwards Lifesciences (EW) to Post Q2 Earnings: What's in Store?

Edwards Lifesciences' (EW) Q2 performance will likely reflect the continued adoption of the RESILIA tissue valves and enhanced sales of the HemoSphere platform.

Edwards Lifesciences (EW) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Edwards Lifesciences (EW) closed at $97.45, marking a -1.99% move from the previous day.

Edwards Lifesciences (EW) Gains But Lags Market: What You Should Know

Edwards Lifesciences (EW) closed the most recent trading day at $98.43, moving +0.46% from the previous trading session.

Here's Why You Should Retain Edwards Lifesciences (EW) Now

Investors are optimistic about Edwards Lifesciences' (EW) strong segmental performance and the growing demand for its RESILIA tissue valves.

Edwards Lifesciences (EW) Gains As Market Dips: What You Should Know

In the latest trading session, Edwards Lifesciences (EW) closed at $96.03, marking a +1.37% move from the previous day.

OCPNY vs. EW: Which Stock Is the Better Value Option?

OCPNY vs. EW: Which Stock Is the Better Value Option?

Edwards Lifesciences (EW) Gains As Market Dips: What You Should Know

Edwards Lifesciences (EW) closed the most recent trading day at $90.79, moving +1.62% from the previous trading session.

Edwards Lifesciences (EW) Stock Moves -1.18%: What You Should Know

In the latest trading session, Edwards Lifesciences (EW) closed at $87.73, marking a -1.18% move from the previous day.

Edwards Lifesciences (EW) Stock Moves -0.68%: What You Should Know

Edwards Lifesciences (EW) closed at $93 in the latest trading session, marking a -0.68% move from the prior day.

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

OCPNY vs. EW: Which Stock Should Value Investors Buy Now?

OCPNY vs. EW: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Stock Reports for Eli Lilly, ConocoPhillips & PNC Financial

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), ConocoPhillips (COP), and The PNC Financial Services Group, Inc. (PNC).

Why Is Edwards Lifesciences (EW) Down 11.8% Since Last Earnings Report?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Analyst Blog Highlights Comcast, CME Group, Charter Communications, Airbnb, and Edwards Lifesciences

Comcast, CME Group, Charter Communications, Airbnb, and Edwards Lifesciences are part of Top analyst Blog.

Mark Vickery headshot

Top Analyst Reports for Comcast, CME & Charter Communications

Today's Research Daily features new research reports on 16 major stocks, including Comcast Corporation (CMCSA), CME Group Inc. (CME), and Charter Communications, Inc. (CHTR).

Here's Why You Should Hold on to Edwards Lifesciences (EW) Now

Investors are optimistic about Edwards Lifesciences (EW) given the strong demand for its RESILIA tissue valves and the PASCAL system.

The Zacks Analyst Blog Highlights T-Mobile US, Deere, PayPal, The PNC Financial Services Group and Edwards Lifesciences

T-Mobile US, Deere, PayPal, The PNC Financial Services Group and Edwards Lifesciences have been included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for T-Mobile, Deere & PayPal

Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Deere & Company (DE), and PayPal Holdings, Inc. (PYPL).

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

IART vs. EW: Which Stock Is the Better Value Option?

IART vs. EW: Which Stock Is the Better Value Option?

Edwards Lifesciences (EW) Q1 Earnings Top Estimates, Margins Up

Increased adoption of the PASCAL platform along with continued strength in the HemoSphere monitoring platform drove Edwards Lifesciences' (EW) Q1 revenues.

Edwards Lifesciences (EW) Beats Q1 Earnings and Revenue Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.45% and 2.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Humana (HUM) Gears Up For Q1 Earnings: What's in the Cards?

Humana's (HUM) first-quarter earnings are likely to reflect the impacts of elevated costs related to investments in technology advancements, partly offset by higher premiums in the Retail segment and sound membership growth.